Valsartan and Amlodipine in Blood Pressure Management: Fixed-Dose vs. Free Drug Therapy

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 114 participants.

Also called NCT06487949

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 114 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT06487949
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Iran (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT06487949. Randomized; quadruple masking; primary purpose treatment. Start 2022-12-01 (actual); primary completion 2023-10-01 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Valsartan and Amlodipine in Blood Pressure Management: Fixed-Dose vs. Free Drug Therapy
Condition
Hypertension
Intervention (Drug)
valsartan-amlodipine 80/5 mg FDC
Intervention (Drug)
valsartan 80 mg and amlodipine 5 mg as free combination
Lead sponsor
Shiraz University of Medical Sciences (class: other)

Record details

Record id
cardio:ct-nct06487949
Content hash
a80f1af7777e28f8ed7c1d8602f80bc51adb6f564a6252e7d0c437c9f022db73